Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol. [PDF]
Hirai I +7 more
europepmc +1 more source
Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase. [PDF]
Zhang J +5 more
europepmc +1 more source
The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate. [PDF]
Wardhani SO +4 more
europepmc +1 more source
Imatinib Mesylate Causes Potential Cardiac Dysfunction in Patients With Chronic Myeloid Leukemia: the Results of a Case-control Study. [PDF]
Shankar G +8 more
europepmc +1 more source
Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate. [PDF]
Siti Mariam I +8 more
europepmc +1 more source
Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review. [PDF]
Bhusal A +9 more
europepmc +1 more source
QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells. [PDF]
Laxane N, Yadav KS.
europepmc +1 more source
Complete laparoscopic wedge resection of a giant locally advanced gastric GIST with near pathological complete response after preoperative treatment with imatinib mesylate: A case report. [PDF]
Guo H +5 more
europepmc +1 more source
Imatinib Mesylate in Cutaneous Melanoma [PDF]
Redondo, Pedro +3 more
openaire +2 more sources

